Page results
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
On Sunday 23 November, the Royal National Orthopaedic Hospital (RNOH) successfully connected to UCLH’s Epic electronic health record (EHR). This is another milestone in our collaboration and digital transformation across North Central London.
-
Colleagues, past and present, came together to mark the tenth anniversary of University College Hospital at Westmoreland Street.
-
One of the FOIA Code of Practice requirements is for public authorities to publish more information about their performance in handling FOIA requests.
-
Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.
-
Patients with an aggressive form of leukaemia will now be able to receive a breakthrough immunotherapy on the NHS which was developed and trialled at UCLH and UCL.
-
Dr Patrick Murphy is a consultant clinical neuropsychologist at the National Hospital for Neurology and Neurosurgery.
-
SUMMIT Study results on the benefits of large-scale screening for lung cancer are published in The Lancet Oncology today (26 March), ahead of the formal addition of lung cancer screening to the UK national screening programme from 1 April.
-
This page has been created by the Oral Surgery department at the Royal National ENT and Eastman Dental Hospitals for patients with a condition which causes painful muscles in the jaw and face. This condition is also known as “Temporomandibular Disorder” or “Myofascial Pain”.
-
This page is designed for parents/carers of children and young people who are scheduled to attend the paediatric audiology department. It outlines the various clinics your child may be seen in on the day of their appointment.
File results
-
FOI/2023/0507 - Mental health patient suicides
-
FOI/2023/0508 - Lynch syndrome clinical pathway
-
FOI/2023/0509 - Immunoglobulin treatments
-
FOI/2023/0514 - Processes and software applications used in Urology
-
FOI/2023/0537 - Agency usage for the Occupational Therapy
-
FOI/2023/0550 - Varicose veins referrals, treatment and wait time
-
FOI/2023/0379 - MDT meetings in relation to tailgut cysts
-
FOI/2023/0589 - International nurse recruitment
-
FOI/2023/0523 - Treatment on Nivolumab
-
FOI/2023/0522 - Urology cancer pathway